REFERENCES
- Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197:157–162.
- Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci. 2011;5:60.
- Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013;32:141–146.
- Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44:832–837.
- Perrone D, Helgesen RD, Fischer RG. United States drug prohibition and legal highs: how drug testing may lead cannabis users to Spice. Drugs Educ Prev Policy. 2013;20:216–224.
- Hu X, Primack BA, Barnett TE, Cook RL. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy. 2011;6:16.
- Johnson LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Survey Results on Drug Use, 1975–2011: Volume I, Secondary School Students. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2012.
- Stephens JL. Synthetic Cannabinoid Usage Among College Students: The Example of K2 and Spice. [master's thesis]. Denton, TX: Univerisity of North Texas; 2011.
- Stogner JM, Miller BL. A spicy kind of high: a profile of synthetic cannabinoid users. Journal of Substance Use. 2014;19(1–2):199–205.
- Winstock AR, Barratt MJ. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend. 2013;131:106–111.
- Castellanos D, Singh S, Thornton G, Avila M, Moreno A. Synthetic cannabinoid use: a case series of adolescents. J Adolesc Health. 2011;49:347–349.
- Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:234–243.
- Substance Abuse and Mental Health Services Administration. The DAWN Report: Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids. Rockville, MD: Office of Applied Studies; 2012.
- Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:93–98.
- Winstock AR, Barratt MJ. The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Hum Psychopharmacol. 2013;28:390–393.
- Lindsay L, White ML. Herbal marijuana alternatives and bath salts—“barely legal” toxic highs. Clin Pediatr Emerg Med. 2012;13:283–291.
- Spaderna M, Addy PH, D'Souza DC. Spicing things up: synthetic cannabinoids. Psychopharmacology (Berl). 2013;228:525–540.
- American Association of Poison Control Centers. Synthetic Marijuana Exposure Calls January 2011–February 2014: Available at http://www.aapcc.org/alerts/synthetic-marijuana/; Accessed April 22 2014.
- Wood KE. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J Pediatr. 2013;163:213–216.
- Monte AA, Bronstein AC, Cao DJ, et al. An outbreak of exposure to a novel synthetic cannabinoid. N Engl J Med. 2014;370:389–390.
- Rodgman C, Kinzie E, Leimbach E. Bad Mojo: use of the new marijuana substitute leads to more and more ED visits for acute psychosis. Am J Emerg Med. 2011;29:232.
- Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus. 2014; 35(2):184–189.
- McLachlan G. Taking the spice out of legal smoking mixtures. Lancet. 2009;374:600.
- Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Delta(9)-THC: mechanism underlying greater toxicity? Life Sci. 2014;97:45–54.
- Sacco LN, Finklea KM. Synthetic Drugs: Overview and Issues for Congress. Washington, DC: Congressional Research Service; 2011.
- 112th Congress. Food and Drug Safety and Innovation Act of 2012, S. 3187. 2012.
- Rhode Island House of Representatives. Rhode Island House Bill 2013-H 5325A. 2013.
- Rhode Island Senate. Rhode Island Senate Bill 2013-S 0454A. 2013.
- Johnson LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Survey Results on Drug Use, 1975–2012: Volume 2, College Students and Adults Ages 19–50. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2013.
- Johnson LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the Future National Survey Results on Drug Use: 1975–2013: Overview, Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2014.
- Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012;120:238–241.
- Johnson LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Survey Results on Drug Use, 1975–2011: Volume II, College Students and Adults Ages 19–50. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2012.
- Gunderson EW. Synthetic cannabinoids: a new frontier of designer drugs. Ann Intern Med. 2013;159:563–564.
- Substance Abuse and Mental Health Services Administration. Results From the 2011 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration 2012. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713.
- Garnier LM, Arria AM, Caldeira KM, Vincent KB, O'Grady KE, Wish ED. Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry. 2010;71:262–269.